Senti Biosciences, Inc.SNTINASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank17
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-50.07M
↓ 37% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-36.56M
Historical baseline
PeriodValueYoY Change
TTM$-50.07M-21.0%
2024$-41.40M+21.0%
2023$-52.40M-50.1%
2022$-34.90M-0.8%
2021$-34.63M-43.3%
2020$-24.17M-31.5%
2019$-18.38M-